Theresa Hahn PhD

Theresa Hahn has extensive experience conducting clinical outcomes research related to blood and marrow transplantation (BMT). She has over 20 years of experience with inter- and intra-programmatic collaborative clinical and translational research to identify, understand and quantify the risk of adverse outcomes and long-term prognosis in hematologic malignancy patients treated with BMT. Her research has investigated outcomes such as graft-versus-host disease, osteoporosis, chemotherapy-associated toxicity, infections, and financial burden, as well as the impact of demographic and sociological factors such as age, obesity, place of residence, race, and socioeconomic status, on long-term prognosis after therapy with BMT.